Vivimed Labs Ltd
22 February 2025 13:36|BSE : 532660|NSE : VIVIMEDLAB|ISIN : INE526G01021
22 February 2025 13:36|BSE : 532660
NSE : VIVIMEDLAB|ISIN : INE526G01021
Vivimed Labs is engaged in the manufacture of Active Pharmaceutical ingredients (API’s), Intermediates and Nutraceutical ingredients with predominance in exports. In addition to generic business, the Company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management.
Vivimed Labs is engaged in the manufacture of Active Pharmaceutical ingredients (API’s), Intermediates and Nutraceutical ingredients with predominance in exports. In addition to generic business, the Company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management.
FAQs
How to buy Vivimed Labs Ltd shares?
What is the current Market Cap of Vivimed Labs Ltd?
What is the current PE and PB ratio of Vivimed Labs Ltd?
Open Free Demat Account
Kickstart your investment journey
